Zantac Pulled from Shelves Citing Probable Contamination of Cancer-Causing Elements

Zantac Pulled from Shelves Citing Probable Contamination of Cancer-Causing Elements

GSK (GlaxoSmithKline) is recalling Zantac, the famous heartburn medicine from all markets. The withdrawal action arrives a few days after the US FDA has discovered improper levels of a carcinogen in the medication. Zantac, commonly available at stores as ranitidine, is a medicine to relieve and prevent heartburn linked with sour stomach and acidity. From 2018, regulators have had recalled some drugs of heart failure and blood pressure. Zantac is the new medicine in which the Food and Drug Administration has discovered impurities, which may lead to cancer. According to…

Read More